A detailed history of Graypoint LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Graypoint LLC holds 8,319 shares of LLY stock, worth $6.62 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
8,319
Previous 7,933 4.87%
Holding current value
$6.62 Million
Previous $7.18 Million 2.62%
% of portfolio
0.49%
Previous 0.51%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $298,046 - $370,567
386 Added 4.87%
8,319 $7.37 Million
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $196,439 - $246,349
271 Added 3.54%
7,933 $7.18 Million
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $152,787 - $204,408
258 Added 3.48%
7,662 $5.96 Million
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $481,074 - $567,123
916 Added 14.12%
7,404 $4.32 Million
Q3 2023

Oct 26, 2023

BUY
$434.7 - $599.3 $314,288 - $433,293
723 Added 12.54%
6,488 $3.48 Million
Q2 2023

Jul 21, 2023

BUY
$350.74 - $468.98 $292,517 - $391,129
834 Added 16.91%
5,765 $2.7 Million
Q1 2023

May 02, 2023

BUY
$310.63 - $364.82 $396,985 - $466,239
1,278 Added 34.98%
4,931 $1.69 Million
Q4 2022

Jan 31, 2023

BUY
$321.55 - $374.67 $83,924 - $97,788
261 Added 7.69%
3,653 $1.34 Million
Q3 2022

Oct 31, 2022

BUY
$296.48 - $337.87 $197,752 - $225,359
667 Added 24.48%
3,392 $1.1 Million
Q2 2022

Aug 01, 2022

BUY
$278.73 - $327.27 $123,477 - $144,980
443 Added 19.41%
2,725 $883,000
Q1 2022

Apr 19, 2022

BUY
$234.69 - $291.66 $28,866 - $35,874
123 Added 5.7%
2,282 $654,000
Q4 2021

Jan 31, 2022

BUY
$224.85 - $279.04 $63,182 - $78,410
281 Added 14.96%
2,159 $596,000
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $13,517 - $16,635
-61 Reduced 3.15%
1,878 $434,000
Q2 2021

Aug 04, 2021

BUY
$180.55 - $233.54 $69,511 - $89,912
385 Added 24.77%
1,939 $445,000
Q1 2021

May 07, 2021

BUY
$164.32 - $212.72 $255,353 - $330,566
1,554 New
1,554 $290,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Graypoint LLC Portfolio

Follow Graypoint LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graypoint LLC, based on Form 13F filings with the SEC.

News

Stay updated on Graypoint LLC with notifications on news.